These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 31994917

  • 21. Serum neutrophil gelatinase-associated lipocalin is associated with cardiovascular events in patients with chronic kidney disease.
    Solak Y, Yilmaz MI, Siriopol D, Saglam M, Unal HU, Yaman H, Gok M, Cetinkaya H, Gaipov A, Eyileten T, Sari S, Yildirim AO, Tonbul HZ, Turk S, Covic A, Kanbay M.
    Int Urol Nephrol; 2015 Dec; 47(12):1993-2001. PubMed ID: 26498629
    [Abstract] [Full Text] [Related]

  • 22. Plasma neutrophil gelatinase-associated lipocalin levels are markedly increased in patients with non-transfusion-dependent thalassemia: Lack of association with markers of erythropoiesis, iron metabolism and renal function.
    Patsaoura A, Tatsi E, Margeli A, Kanavaki I, Delaporta P, Kyriakopoulou D, Kouraklis-Symeonidis A, Kattamis A, Papassotiriou I.
    Clin Biochem; 2014 Aug; 47(12):1060-4. PubMed ID: 24721683
    [Abstract] [Full Text] [Related]

  • 23. Measurement of neutrophil gelatinase-associated lipocalin (NGAL) in patients with non-communicable diseases: any additional benefit?
    Ezenwaka CE, Idris S, Davis G, Roberts L.
    Arch Physiol Biochem; 2016 Aug; 122(2):70-4. PubMed ID: 26745339
    [Abstract] [Full Text] [Related]

  • 24. Serum neutrophil gelatinase-associated lipocalin and cystatin C are early biomarkers of contrast-induced nephropathy after coronary angiography in patients with chronic kidney disease.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 May; 65(5):436-42. PubMed ID: 23580616
    [Abstract] [Full Text] [Related]

  • 25. Serum and urinary neutrophil gelatinase-associated lipocalin levels in children with chronic renal diseases.
    Nishida M, Kawakatsu H, Okumura Y, Hamaoka K.
    Pediatr Int; 2010 Aug; 52(4):563-8. PubMed ID: 20059722
    [Abstract] [Full Text] [Related]

  • 26. Urine neutrophil gelatinase-associated lipocalin levels do not improve risk prediction of progressive chronic kidney disease.
    Liu KD, Yang W, Anderson AH, Feldman HI, Demirjian S, Hamano T, He J, Lash J, Lustigova E, Rosas SE, Simonson MS, Tao K, Hsu CY, Chronic Renal Insufficiency Cohort (CRIC) study investigators.
    Kidney Int; 2013 May; 83(5):909-14. PubMed ID: 23344473
    [Abstract] [Full Text] [Related]

  • 27. Plasma neutrophil gelatinase associated lipocalin (NGAL) is associated with kidney function in uraemic patients before and after kidney transplantation.
    Magnusson NE, Hornum M, Jørgensen KA, Hansen JM, Bistrup C, Feldt-Rasmussen B, Flyvbjerg A.
    BMC Nephrol; 2012 Feb 10; 13():8. PubMed ID: 22325322
    [Abstract] [Full Text] [Related]

  • 28. Neutrophil gelatinase-associated lipocalin (NGAL) and kidney injury molecule 1 (KIM-1) as predictors of incident CKD stage 3: the Atherosclerosis Risk in Communities (ARIC) Study.
    Bhavsar NA, Köttgen A, Coresh J, Astor BC.
    Am J Kidney Dis; 2012 Aug 10; 60(2):233-40. PubMed ID: 22542304
    [Abstract] [Full Text] [Related]

  • 29. Urinary neutrophil gelatinase-associated lipocalin and clinical outcomes in chronic kidney disease patients.
    Lin HY, Hwang DY, Lee SC, Kuo HT, Kuo MC, Chang JM, Tsai JC, Hung CC, Hwang SJ, Chen HC.
    Clin Chem Lab Med; 2015 Jan 10; 53(1):73-83. PubMed ID: 25153411
    [Abstract] [Full Text] [Related]

  • 30. Effect of glomerular filtration rate impairment on diagnostic performance of neutrophil gelatinase-associated lipocalin and B-type natriuretic peptide as markers of acute cardiac and renal failure in chronic kidney disease patients.
    Donadio C.
    Crit Care; 2014 Feb 28; 18(1):R39. PubMed ID: 24581340
    [Abstract] [Full Text] [Related]

  • 31. Urinary neutrophil gelatinase-associated lipocalin distinguishes pre-renal from intrinsic renal failure and predicts outcomes.
    Singer E, Elger A, Elitok S, Kettritz R, Nickolas TL, Barasch J, Luft FC, Schmidt-Ott KM.
    Kidney Int; 2011 Aug 28; 80(4):405-14. PubMed ID: 21412214
    [Abstract] [Full Text] [Related]

  • 32. Value of urine/serum Neutrophil gelatinase-associated lipocalin ratio in distinguishing acute kidney injury from chronic kidney disease.
    Huang Z, Wu L, Zeng M, Wu B, Xu X, Mao H, Yuan Y, Xing C.
    Clin Chim Acta; 2022 Feb 01; 526():23-29. PubMed ID: 34958753
    [Abstract] [Full Text] [Related]

  • 33. Performance of urinary kidney injury molecule-1, neutrophil gelatinase-associated lipocalin, and N-acetyl-β-D-glucosaminidase to predict chronic kidney disease progression and adverse outcomes.
    Lobato GR, Lobato MR, Thomé FS, Veronese FV.
    Braz J Med Biol Res; 2017 Mar 30; 50(5):e6106. PubMed ID: 28380198
    [Abstract] [Full Text] [Related]

  • 34. Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in heart allograft recipients.
    Przybylowski P, Malyszko J, Malyszko JS.
    Transplant Proc; 2010 Jun 30; 42(5):1797-802. PubMed ID: 20620526
    [Abstract] [Full Text] [Related]

  • 35. Association of plasma neutrophil gelatinase-associated lipocalin with parameters of CKD-MBD in maintenance hemodialysis patients.
    Jia XY, Wei K, Chen J, Xi LH, Kong XL, Wei Y, Wang L, Wang ZS, Liu YP, Liang LM, Xu DM.
    J Bone Miner Metab; 2021 Nov 30; 39(6):1058-1065. PubMed ID: 34392464
    [Abstract] [Full Text] [Related]

  • 36. Comparison of Neutrophil Gelatinase-Associated Lipocalin Versus B-Type Natriuretic Peptide and Cystatin C to Predict Early Acute Kidney Injury and Outcome in Patients With Acute Heart Failure.
    Palazzuoli A, Ruocco G, Pellegrini M, De Gori C, Del Castillo G, Franci B, Nuti R, Ronco C.
    Am J Cardiol; 2015 Jul 01; 116(1):104-11. PubMed ID: 25943992
    [Abstract] [Full Text] [Related]

  • 37. Serum neutrophil gelatinase-associated lipocalin concentration reflects severity of coronary artery disease in patients without heart failure and chronic kidney disease.
    Katagiri M, Takahashi M, Doi K, Myojo M, Kiyosue A, Ando J, Hirata Y, Komuro I.
    Heart Vessels; 2016 Oct 01; 31(10):1595-602. PubMed ID: 26614309
    [Abstract] [Full Text] [Related]

  • 38. Urinary neutrophil gelatinase-associated lipocalin as a predictor of cardiovascular events in patients with chronic kidney disease.
    Hasegawa M, Ishii J, Kitagawa F, Takahashi K, Hayashi H, Koide S, Tomita M, Takahashi H, Ozaki Y, Yuzawa Y.
    Heart Vessels; 2015 Jan 01; 30(1):81-8. PubMed ID: 24378882
    [Abstract] [Full Text] [Related]

  • 39. Serum and Urine Neutrophil Gelatinase-Associated Lipocalin Levels Measured at Admission Predict Progression to Chronic Kidney Disease in Sepsis-Associated Acute Kidney Injury Patients.
    Tuan PNH, Quyen DBQ, Van Khoa H, Loc ND, Van My P, Dung NH, Toan ND, Quyet D, Thang LV.
    Dis Markers; 2020 Jan 01; 2020():8883404. PubMed ID: 32908617
    [Abstract] [Full Text] [Related]

  • 40. Neutrophil gelatinase-associated lipocalin as an early marker of contrast-induced nephropathy after coronary angiography.
    Alharazy SM, Kong N, Saidin R, Gafor AH, Maskon O, Mohd M, Zakaria SZ.
    Angiology; 2014 Mar 01; 65(3):216-23. PubMed ID: 23378196
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.